AMGEN ONCOLOGY
See life break through™
BiTE
THE ENGAGERTM
THE BiTE® UNIVERSE IS EXPANDING WITH
THE GOAL OF TARGETING MULTIPLE TUMOR TYPES
KRASG12C
Despite 40 years of research, KRAS remains an elusive target—has science found a way to target this common oncogenic protein?
A Broad and
Diverse Pipeline
Science
From innovative modalities to unique pathways, see how we’re advancing oncology treatment
PIPELINE
Explore our investigational agents and clinical trials across a range of solid tumors and hematologic malignancies
Resources
View and download a wealth of educational resources for personal use
About Amgen Oncology
Changing the course of cancer treatment for more than 40 years